NCT03640234View on ClinicalTrials.gov

Return of Actionable Variants Empirical Study

CompletedOBSERVATIONAL
Enrollment

418

Participants

Timeline

Start Date

February 25, 2016

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions
Familial Hypercholesterolemia
Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Human Genome Research Institute (NHGRI)

NIH

lead

Mayo Clinic

OTHER

NCT03640234 - Return of Actionable Variants Empirical Study | Biotech Hunter | Biotech Hunter